AMEX · SRXH

SRX Global Inc.

$1.80 $0.00 (+0.00%) 1D After hours

Key Metrics

$35.13M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow
Beta · 1Y 1.07
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 8
    The stock moved +45.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 8
  • Jul 7
    From its Jun 17 high, the share price fell 89%.

    Peak close $11.97 on Jun 17; trough close $1.35 on Jul 7. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -89%
  • Jul 6
    The stock moved -66.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 6

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$35.13M
Enterprise value$11.59M
Shares outstanding19.5M
52-wk range$0.19 – $16.27
Avg volume · 20D6.3M
Net cash $23.54M
Book value / share$0.94
IndustryBeverages
ExchangeAMEX
About SRX Global Inc.
IPO dateApr 30, 2025
Employees11

SRX Global Inc is an AI-driven platform focused on investing in operating companies, strategic assets, and technology-enabled opportunities across multiple sectors. It uses technology and data analytics to identify and manage investments.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio1.72
Quick ratio1.64
Debt / equity0.00
Debt / EBITDA
Net cash $23.54M
Working capital$18.07M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings